MRKR – marker therapeutics, inc. (US:NASDAQ)

News

Marker Therapeutics (NASDAQ:MRKR) was downgraded by analysts at Wall Str
Marker Therapeutics (NASDAQ:MRKR) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates [Yahoo! Finance]
Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com